| Title: | Analysis of ATP7A expression and ceruloplasmin levels as biomarkers in patients undergoing neoadjuvant chemotherapy for advanced high-grade serous ovarian carcinoma |
|---|
| Authors: | ID Lukanović, David (Author)
ID Polajžer, Sara (Author)
ID Matjašič, Miha (Author)
ID Kobal, Borut (Author)
ID Černe, Katarina (Author) |
|---|
| Files: |  PDF - Presentation file, download (1,77 MB)
MD5: 83BB9482E2F48171A3CEF772869D3C85
 URL - Source URL, visit https://www.mdpi.com/1422-0067/25/18/10195
|
|---|
| Language: | English |
|---|
| Typology: | 1.01 - Original Scientific Article |
|---|
| Organization: |  UKC LJ - Ljubljana University Medical Centre
|
|---|
| Abstract: | Ovarian cancer (OC), particularly high-grade serous carcinoma (HGSC), is a leading cause of gynecological cancer mortality due to late diagnosis and chemoresistance. While studies on OC cell lines have shown that overexpression of the ATP7A membrane transporter correlates with resistance to platinum-based drugs (PtBMs) and cross-resistance to copper (Cu), clinical evidence is lacking. The functionality of ceruloplasmin (CP), the main Cu-transporting protein in the blood, is dependent on, among other things, ATP7A activity. This study investigated ATP7A expression and CP levels as potential biomarkers for predicting responses to PtBMs. We included 28 HGSC patients who underwent neoadjuvant chemotherapy (NACT). ATP7A expression in ovarian and peritoneal tissues before NACT and in peritoneal and omental tissues after NACT was analyzed via qPCR, and CP levels in ascites and plasma were measured via ELISA before and after NACT. In total, 54% of patients exhibited ATP7A expression in pretreatment tissue (ovary and/or peritoneum), while 43% of patients exhibited ATP7A expression in tissue after treatment (peritoneum and/or omentum). A significant association was found between higher ATP7A expression in the peritoneum before NACT and an unfavorable CA-125 elimination rate constant k (KELIM) score. Patients with omental ATP7A expression had significantly higher plasma mean CP levels before NACT. Plasma CP levels decreased significantly after NACT, and higher CP levels after NACT were associated with a shorter platinum-free interval (PFI). These findings suggest that the ATP7A transporter and CP have the potential to serve as predictive markers of chemoresistance, but further research is needed to validate their clinical utility. |
|---|
| Keywords: | ATP7A, transporter, ceruloplasmin, ovarian cancer, high-grade serous carcinoma, chemoresistance, predictive marker |
|---|
| Publication status: | Published |
|---|
| Publication version: | Version of Record |
|---|
| Year of publishing: | 2024 |
|---|
| Number of pages: | str. 1-18 |
|---|
| Numbering: | Vol. 25, iss. 18, [article no.] 10195 |
|---|
| PID: | 20.500.12556/DiRROS-29991  |
|---|
| UDC: | 618.1-006.6 |
|---|
| ISSN on article: | 1422-0067 |
|---|
| DOI: | 10.3390/ijms251810195 |
|---|
| COBISS.SI-ID: | 208937219 |
|---|
| Note: | Nasl. z nasl. zaslona;
Opis vira z dne 25. 9. 2024;
|
|---|
| Publication date in DiRROS: | 11.06.2026 |
|---|
| Views: | 90 |
|---|
| Downloads: | 57 |
|---|
| Metadata: |    |
|---|
|
:
|
Copy citation |
|---|
| | | | Share: |  |
|---|
Hover the mouse pointer over a document title to show the abstract or click
on the title to get all document metadata. |
